{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-070673","form_type":"8-K","ticker":"OVID","cik":"0001636651","company_name":"Ovid Therapeutics Inc.","filed_at":"2024-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.362102+00:00","generated_at":"2026-06-01T05:35:51.495844+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Ovid Therapeutics stockholders elect directors, approve executive compensation, ratify KPMG","bullets":["Proposal 1: Barbara Duncan and Robert Michael Poole elected to board; For votes 36.7M and 40.2M respectively.","Proposal 2: Advisory vote on executive compensation approved with 40.5M For, 1.76M Against, 0.01M Abstain.","Proposal 3: Ratification of KPMG as auditor for FY2024 passed with 57.2M For, 1.29M Against, 9,375 Abstain.","Broker non-votes totaled 16.2M shares on Proposals 1 and 2."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-070673","json":"https://secwatch.observer/filing/0000950170-24-070673.json","markdown":"https://secwatch.observer/filing/0000950170-24-070673.md","text":"https://secwatch.observer/filing/0000950170-24-070673.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1636651/000095017024070673/0000950170-24-070673-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1636651/000095017024070673/ovid-20240607.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:35:51.495844+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}